Global Autoinjectors Market Size and Forecast 2023-2032|AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton,

The Autoinjectors Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Autoinjectors Market:

https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report

According to The Business Research Company’s Autoinjectors Global Market Report 2024, The autoinjectors market size has grown exponentially in recent years. It will grow from $3.06 billion in 2023 to $3.79 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, growth in aging population, rise in biotechnology and pharmaceutical sector, rise in patient preference for self-administration, regulatory support.

The autoinjectors market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 21.9%. The growth in the forecast period can be attributed to expansion of therapeutic applications, rising healthcare costs, increased focus on patient-centered care, telemedicine and remote patient monitoring, emerging markets. Major trends in the forecast period include personalized drug delivery, connected and smart autoinjectors, needle-free autoinjectors, biologic drug delivery, safety and security features.

The increasing prevalence of chronic diseases is expected to fuel the growth of the autoinjectors market in the coming years. Chronic diseases are described as illnesses that last a year or longer and necessitate continuing medical attention. Chronic diseases such as heart disease, cancer, rheumatoid arthritis, and diabetes are the world’s top causes of mortality and disability. Auto injection devices are intended for multiple injections of biologics and hormones in patients who require regular dosage for long-term management of medical circumstances such as diabetes and rheumatoid arthritis. For instance, according to the Imperial College London research in 2020, chronic diseases are expected to kill almost 41 million people globally each year, accounting for seven out of ten fatalities. Around 17 million of these fatalities are classified as premature, with people dying substantially younger than predicted on average. Therefore, the increasing prevalence of chronic diseases drives the growth of the autoinjectors market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=5249&type=smp

The autoinjectors market covered in this report is segmented –

1) By Type: Disposable Autoinjectors, Reusable Autoinjectors

2) By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies

3) By Route Of Administration: Subcutaneous, Intramuscular

4) By Distribution Channel: Online Retailer, Pharmacy

5) By End User: Home Care Settings, Hospitals And Clinics, Other End-Users

The growing technological advancements are shaping the autoinjectors market. Major players operating in the autoinjectors sector are focused on developing technological solutions for autoinjectors to meet the demand for a viscous biologics delivery mechanism. For instance, in February 2021, Becton Dickinson (BD), a US-based medical device company is developing Intevia 2.25 mL based on thinner wall cannula technology. The Intevia 2.25 mL is a patient-centric device that works seamlessly with BD Neopak XtraFlow prefillable syringes and has an 8-millimeter needle with a thinner wall.

The autoinjectors market report table of contents includes:

1. Executive Summary

2. Autoinjectors Market Characteristics

3. Autoinjectors Market Trends And Strategies

4. Autoinjectors Market – Macro Economic Scenario

5. Global Autoinjectors Market Size and Growth

26. South America Autoinjectors Market

27. Brazil Autoinjectors Market

28. Middle East Autoinjectors Market

29. Africa Autoinjectors Market

30. Autoinjectors Market Competitive Landscape And Company Profiles

Top Major Players: